TMS Therapy is a new treatment cleared by the US Food and Drug Administration (FDA) for patients suffering from depression who have not achieved satisfactory improvement from prior antidepressant treatment.
TMS Therapy is performed in a psychiatric office, under the supervision of Dr. Deirmenjian, using a medical device called the NeuroStar TMS Therapy system. The typical initial treatment course consists of at least 5 treatments per week over a 4-6 week period, for an average of 20-30 total treatments. Each treatment session lasts approximately 40 minutes.
- TMS is non-invasive, meaning that it does not involve surgery, anesthesia, or sedation. In fact, the patient remains awake and alert during the treatment.
- TMS is non-systemic, meaning that, unlike medication, it is a treatment focused on a particular brain area and does not circulate in the bloodstream throughout the body.